Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:272 (10 February), doi:10.1136/bmj.39112.454387.BE
Healthcare systems should follow the lead developed in other high risk industries
| The first 150 words of the full text of this article appear below. |
Like most treatments, radiotherapy has the power to heal but also to harm.1 Worldwide, around 10 million people are newly diagnosed with cancer each year and 40-50% will receive radiotherapy.2 In the United Kingdom, around 200 linear accelerators deliver 100 000 courses of radiotherapy in 1.5 million fractions annually; this results in roughly 4.25 million doses of radiation for cancer treatment each year (data from the Health Protection Agency (www.hpa.org.uk/) and the National Cancer Services Analysis Team (www.canceruk.net/)).
Because of the hazardous nature of radiation, an extensive framework of protocols, standards, and legislation is in place to protect patients and healthcare workers.3 4 5 6 The World Health Organization World Alliance for Patient Safety has this year taken up the challenge of making radiotherapy safer (www.who.int/patientsafety/en). It will deal with two key questions. Firstly, can standardised safety interventions be developed that reliably and consistently reduce the risk
Liam Donaldson, chief medical officer for England
1 Department of Health, London SW1A 2NS
liam.donaldson@dh.gsi.gov.uk
Read all Rapid Responses